Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrizia Stoitzner

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
The Journal of Investigative Dermatology|June 30, 2015
Impaired gp100-Specific CD8(+) T-Cell Responses in the Presence of Myeloid-Derived Suppressor Cells in a Spontaneous Mouse Melanoma ModelDavid G Mairhofer, Daniela Ortner, Christoph H Tripp, et al.
Blood|October 5, 2013
The late endosomal adaptor molecule p14 (LAMTOR2) represents a novel regulator of Langerhans cell homeostasisFlorian Sparber, Julia M Scheffler, Nicole Amberg, et al.
Journal of Leukocyte Biology|July 20, 2006
The dermal microenvironment induces the expression of the alternative activation marker CD301/mMGL in mononuclear phagocytes, independent of IL-4/IL-13 signalingMarcel Dupasquier, Patrizia Stoitzner, Hui Wan, et al.
Frontiers in Immunology|November 8, 2021
Specific Protein Antigen Delivery to Human Langerhans Cells in Intact SkinMareike Rentzsch, Robert Wawrzinek, Claudia Zelle-Rieser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2009
Targeting antigen to MHC class II molecules promotes efficient cross-presentation and enhances immunotherapyNina Dickgreber, Patrizia Stoitzner, Yan Bai, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 11, 2022
Early antitumor activity of oral Langerhans cells is compromised by a carcinogenYasmin Saba, Itay Aizenbud, Daniela Matanes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 27, 2011
ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cellsPeter Duewell, Ulrich Kisser, Klaus Heckelsmiller, et al.
Molecular Oncology|July 3, 2020
Epidermal activation of Hedgehog signaling establishes an immunosuppressive microenvironment in basal cell carcinoma by modulating skin immunitySandra Grund-Gröschke, Daniela Ortner, Antal B Szenes-Nagy, et al.
European Journal of Immunology|July 12, 2013
Lapatinib and doxorubicin enhance the Stat1-dependent antitumor immune responseLára Hannesdóttir, Piotr Tymoszuk, Nirmala Parajuli, et al.
ACS Central Science|May 30, 2019
A Specific, Glycomimetic Langerin Ligand for Human Langerhans Cell TargetingEike-Christian Wamhoff, Jessica Schulze, Lydia Bellmann, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
The Journal of Investigative Dermatology|June 30, 2015
Impaired gp100-Specific CD8(+) T-Cell Responses in the Presence of Myeloid-Derived Suppressor Cells in a Spontaneous Mouse Melanoma ModelDavid G Mairhofer, Daniela Ortner, Christoph H Tripp, et al.
Blood|October 5, 2013
The late endosomal adaptor molecule p14 (LAMTOR2) represents a novel regulator of Langerhans cell homeostasisFlorian Sparber, Julia M Scheffler, Nicole Amberg, et al.
Journal of Leukocyte Biology|July 20, 2006
The dermal microenvironment induces the expression of the alternative activation marker CD301/mMGL in mononuclear phagocytes, independent of IL-4/IL-13 signalingMarcel Dupasquier, Patrizia Stoitzner, Hui Wan, et al.
Frontiers in Immunology|November 8, 2021
Specific Protein Antigen Delivery to Human Langerhans Cells in Intact SkinMareike Rentzsch, Robert Wawrzinek, Claudia Zelle-Rieser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2009
Targeting antigen to MHC class II molecules promotes efficient cross-presentation and enhances immunotherapyNina Dickgreber, Patrizia Stoitzner, Yan Bai, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 11, 2022
Early antitumor activity of oral Langerhans cells is compromised by a carcinogenYasmin Saba, Itay Aizenbud, Daniela Matanes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 27, 2011
ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cellsPeter Duewell, Ulrich Kisser, Klaus Heckelsmiller, et al.
Molecular Oncology|July 3, 2020
Epidermal activation of Hedgehog signaling establishes an immunosuppressive microenvironment in basal cell carcinoma by modulating skin immunitySandra Grund-Gröschke, Daniela Ortner, Antal B Szenes-Nagy, et al.
European Journal of Immunology|July 12, 2013
Lapatinib and doxorubicin enhance the Stat1-dependent antitumor immune responseLára Hannesdóttir, Piotr Tymoszuk, Nirmala Parajuli, et al.
ACS Central Science|May 30, 2019
A Specific, Glycomimetic Langerin Ligand for Human Langerhans Cell TargetingEike-Christian Wamhoff, Jessica Schulze, Lydia Bellmann, et al.
Pageof 10